<unk>  is usually reserved to treat moderate to severe nosocomial pneumonia, infections caused by multiple drug-resistant microorganisms (e.g. Pseudomonas aeruginosa) and empirical treatment of febrile neutropenia.<unk>  has good activity against important pathogens including Pseudomonas aeruginosa, Staphylococcus aureus, and multiple drug-resistant Streptococcus pneumoniae. A particular strength is its activity against Enterobacteriaceae. Whereas other cephalosporins are degraded by many plasmid- and chromosome-mediated beta-lactamases,<unk>  is stable and is a front-line agent when infection with Enterobacteriaceae is known or suspected. Spectrum of bacterial susceptibility<unk>  is a broad-spectrum cephalosporin antibiotic and has been used to treat bacteria responsible for causing pneumonia and infections of the skin and urinary tract. Some of these bacteria include Pseudomonas, Escherichia, and Streptococcus species. The following represents MIC susceptibility data for a few medically significant microorganisms: * Escherichia coli: ≤0.007 – 128 μg/ml * Pseudomonas aeruginosa: 0.06 – >256 μg/ml * Streptococcus pneumoniae: ≤0.007 – >8 μg/ml
Cefepime
Meropenem
Azithromycin
Levofloxacin
Aztreonam
Imipenem
Vancomycin
Telithromycin